Elicio raises CEO/CSO base pay, grants 225k/30k stock options, adopts severance plan

Elicio Therapeutics, Inc.

CEO base salary raised to $608,400; annual performance bonus opportunity set at 55% of base.
CSO base salary increased to $460,000; annual performance bonus opportunity set at 40% of base.
Stock options granted: 225,137 shares to CEO, 29,800 shares to CSO; vest 25% on first anniversary then monthly.
New Executive Severance Plan provides salary-based multipliers for normal and change-in-control severance, plus equity acceleration.
Severance benefits require a release and are conditioned on compliance with restrictive covenants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.